Boutin JA - Search Results

1

Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.

Poissonnier-Durieux S, Ettaoussi M, Pérès B, Boutin JA, Audinot V, Bennejean C, Delagrange P, Caignard DH, Renard P, Berthelot P, Lesieur D, Yous S. Poissonnier-Durieux S, et al. Among authors: boutin ja. Bioorg Med Chem. 2008 Sep 15;16(18):8339-48. doi: 10.1016/j.bmc.2008.08.052. Epub 2008 Aug 27. Bioorg Med Chem. 2008. PMID: 18778943

2

Screening of ligand binding on melatonin receptor using non-peptide combinatorial libraries.

Boutin JA, Lahaye C, Pegurier C, Nicolas JP, Fauchere JL, Langlois M, Renard P, Delagrange P, Canet E. Boutin JA, et al. J Recept Signal Transduct Res. 2000 Jan;20(1):105-18. doi: 10.3109/10799890009150040. J Recept Signal Transduct Res. 2000. PMID: 10711500

3

Substrate specificity and inhibition studies of human serotonin N-acetyltransferase.

Ferry G, Loynel A, Kucharczyk N, Bertin S, Rodriguez M, Delagrange P, Galizzi JP, Jacoby E, Volland JP, Lesieur D, Renard P, Canet E, Fauchère JL, Boutin JA. Ferry G, et al. Among authors: boutin ja. J Biol Chem. 2000 Mar 24;275(12):8794-805. doi: 10.1074/jbc.275.12.8794. J Biol Chem. 2000. PMID: 10722724 Free article.

4

Identification of the melatonin-binding site MT3 as the quinone reductase 2.

Nosjean O, Ferro M, Coge F, Beauverger P, Henlin JM, Lefoulon F, Fauchere JL, Delagrange P, Canet E, Boutin JA. Nosjean O, et al. Among authors: boutin ja. J Biol Chem. 2000 Oct 6;275(40):31311-7. doi: 10.1074/jbc.M005141200. J Biol Chem. 2000. PMID: 10913150 Free article.

5

Synthesis of a small library of phenylalkylamide derivatives as melatoninergic ligands for human mt1 and MT2 receptors.

Pégurier C, Curtet S, Nicolas JP, Boutin JA, Delagrange P, Renard P, Langlois M. Pégurier C, et al. Among authors: boutin ja. Bioorg Med Chem. 2000 Jan;8(1):163-71. doi: 10.1016/s0968-0896(99)00285-0. Bioorg Med Chem. 2000. PMID: 10968275

6

Synthesis of phenalene and acenaphthene derivatives as new conformationally restricted ligands for melatonin receptors.

Jellimann C, Mathé-Allainmat M, Andrieux J, Kloubert S, Boutin JA, Nicolas JP, Bennejean C, Delagrange P, Langlois M. Jellimann C, et al. Among authors: boutin ja. J Med Chem. 2000 Nov 2;43(22):4051-62. doi: 10.1021/jm000922c. J Med Chem. 2000. PMID: 11063602

7

Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2.

Nosjean O, Nicolas JP, Klupsch F, Delagrange P, Canet E, Boutin JA. Nosjean O, et al. Among authors: boutin ja. Biochem Pharmacol. 2001 Jun 1;61(11):1369-79. doi: 10.1016/s0006-2952(01)00615-3. Biochem Pharmacol. 2001. PMID: 11331072

8

[125I]-S36057: a new and highly potent radioligand for the melanin-concentrating hormone receptor.

Audinot V, Lahaye C, Suply T, Beauverger P, Rodriguez M, Galizzi JP, Fauchère JL, Boutin JA. Audinot V, et al. Among authors: boutin ja. Br J Pharmacol. 2001 Jun;133(3):371-8. doi: 10.1038/sj.bjp.0704085. Br J Pharmacol. 2001. PMID: 11375253 Free PMC article.

9

Synthesis of nitroindole derivatives with high affinity and selectivity for melatoninergic binding sites MT(3).

Leclerc V, Yous S, Delagrange P, Boutin JA, Renard P, Lesieur D. Leclerc V, et al. Among authors: boutin ja. J Med Chem. 2002 Apr 25;45(9):1853-9. doi: 10.1021/jm011053+. J Med Chem. 2002. PMID: 11960497

10

A convenient 3-step synthesis of 3-acetamido-6-arylpyridazines directed to novel Y5 receptor antagonist.

Guéry S, Rival Y, Wermuth CG, Renard P, Boutin JA. Guéry S, et al. Among authors: boutin ja. Chem Pharm Bull (Tokyo). 2002 May;50(5):636-9. doi: 10.1248/cpb.50.636. Chem Pharm Bull (Tokyo). 2002. PMID: 12036018 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

287 results

Search Page

Filters